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Abstract
Background: Oral health care of patients with acquired immune deficiency syndrome (AIDS) due to human
immunodeficiency virus (HIV) is a growing area of concern, taking into consideration the increased life expectancy
of patients resulting from antiretroviral therapy. There is insufficient literature regarding the impact of dental
implants in AIDS patients. This study investigated the long-term clinical outcome of implant placement in patients
diagnosed with AIDS.
Methods: This monocentric study included AIDS patients with CD4 <200 cells/μL, age 18 years or older, and a
minimum of one edentulous space requiring implant. All patients in the study were undergoing highly active
antiretroviral therapy (HAART). HAART includes nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside
reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs).
Typical treatment includes two different NTRIs, along with a third drug, either an INSTI, a PI, or an NNRTI. Bicon
dental implants were placed in the patients after medical clearance and were followed up for 5 years. Bicon system
implants were chosen because of availability and previous experience with this brand. Implant success criteria are
defined as implants that had no clinical mobility at uncovering, no radiographic radiolucency, and allowed for
loading and abutment placement. Implant success in AIDS patients was measured over a period of 5 years.
Descriptive statistics were used.
Results: Sixteen adults met the inclusion criteria (12 males and 4 females) with mean CD4 count as 141.25 (sd 35.5).
Thirty-three implants were placed in selected patients. Average time to uncovering was 151 days (sd 25 days). Two
of the three failures were maxillary implants in the anterior arch, and the third was in the mandibular posterior arch.
Conclusions: The study found a slightly higher failure rate of 10 % in patients with AIDS, compared to widely
accepted failure rates in healthy patients at 5–7 %. With the advent of new medical therapies, even AIDS patients
should be offered the option of root-formed implants as a viable alternative to fixed and removable prosthetics.
Background
The Joint United Nations Programme on HIV/AIDS
estimates that 36.9 million (34.3–41.4 million) people
are living with human immunodeficiency virus (HIV) in-
fection [1]. In America, the Centers for Disease Control
and Prevention (CDC) estimated that 1.2 million people
aged 13 or older were HIV infected by the end of 2012
[2] and the cumulative population of persons surviving
for more than 36 months after an acquired immune
deficiency syndrome (AIDS) diagnosis to be 83 % [3]. As
with the non-infected population, AIDS patients are in
need of routine dental care, including implants. Accord-
ing to a 2015 systemic review, there have been only nine
high-quality studies that have examined the implant out-
comes in HIV-positive patients [4] and no studies look-
ing at the implant outcomes in patients with the
diagnosis of AIDS with a long-term follow-up. For this
reason, a new prospective cohort study is needed.
Although a great deal of research has been conducted in
the pathophysiology, epidemiology, and treatment of
AIDS, little is known with regard to the predictability of
dental implants in this population. The purpose of this
study is to evaluate implant outcomes in patients who
have a diagnosis of AIDS, in order to provide some con-
crete data that may guide the dental practitioner and our
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medical counterparts when faced with treatment plan-
ning of these patients.
Methods
Our study is a prospective study looking at the failure
rates in root-formed implants in AIDS patients at 5 years
post-surgical placement of the implant fixtures. Patients
recruited for the study had to meet inclusion criteria
which included diagnosis of AIDS measured by a pre-
operative cluster of differentiation 4 (CD4) <200 cells/
μL, age 18 years or older, and a minimum of one edentu-
lous space requiring an implant as a viable restorative
option. Exclusion criteria included current smokers,
active periodontal disease, and non-restored remaining
dentition. The study was conducted at a North Carolina
community health center which serves a large group of
patients infected with HIV, of which a substantial num-
ber met the CDC criteria for AIDS, CD4 <200 cells/μL
[5]. All participants recruited for the study were patients
of the health center under the care of the center’s HIV
specialist and were patients of record of the center’s
dental clinic. Patients did not receive any financial com-
pensation for participating in the study. Internal review
board approval was granted for this study.
Bicon® root-formed implants were placed in all patients.
These implants were chosen because of availability and
previous experience with this brand. All patients that met
the inclusion criteria gave consent and had a pre-
operative discussion on the risks associated with implant
surgery. All cases were presented at implant rounds, and a
comprehensive restorative work-up including panoramic
and periapical radiographs, study models, and treatment
plan was completed prior to surgical placement of any im-
plants. Pre-operative medical work-up included medical
clearance by the patients’ physician, CD4 counts, and viral
loads. No perioperative antibiotics were given.
Post-operatively, all patients were placed on chlorhexi-
dine gluconate 0.12 % rinse. No post-operative antibiotics
were prescribed. All patients in the study were undergoing
highly active antiretroviral therapy (HAART). HAART in-
cludes nucleoside reverse transcriptase inhibitors (NRTIs),
non-nucleoside reverse transcriptase inhibitors (NNRTIs),
protease inhibitors (PIs), and integrase strand transfer in-
hibitors (INSTIs). Typical treatment includes two different
NTRIs, along with a third drug, either an INSTI, a PI, or
an NNRTI. Patients on HAART and Pneumocystis
pneumonia (PCP) prophylactic medications were told to
continue their current regimen. All implants were placed
by the same two dental surgeons, and all patients were
followed by the center’s HIV/AIDS specialist. Patients were
followed up at 1 week, 4 weeks, at uncovering (4–7 months),
and then yearly till 5 years. The bone quality and
consistency of this cohort did not differ from the same age
and gender non-AIDS population. Infection, mobility, need
for implant removal, non-bony union, and clinical mobility
were considered to be implant failures. Implants with
exposed threads were considered failures. Implant success
criteria constituted implants that had no clinical mobility at
uncovering, no radiographic radiolucency, and allowed for
loading and abutment placement.
Standard descriptive statistics were used to examine the
distribution of key variables (age, gender, CD4 count at
baseline and follow-up, and failure rate) in the sample.
Due to the small sample size in this study (n = 16), the re-
lationship of CD4 count and failure will be examined
graphically and cases which failed are discussed individu-
ally in the “Results” section. A bar chart is presented to
examine the relationship between implant survival and
CD4 count at baseline. A non-parametric survival curve
(using the Kaplan-Meier method) is estimated for individ-
ual implants (n = 33), which depicts the relationship
between implant survivorship and time since procedure.
Results
Descriptive statistics are presented in Table 1. Sixteen
(n = 16) patients met our inclusion criteria and were
included in our study. The sample included 12 males
and 4 females. The mean age at enrollment was
36.2 years (sd 8.83 years). The mean CD4 count at the
time of placement was 141.25 (sd 35.5). A total of 33
implants were placed in the 16 patients, including 5
mandibular implants and 28 maxillary implants. The
average time to uncovering was 151 days (sd 25 days)
for all implants that did not fail. Tables 2 and 3 present
Table 1 Descriptive statistics (n = 16 patients)
Variable Number Mean (percentage) Standard deviation
Age (years) 16 36.19 8.83
Sex Male 12 (75) –
Female 4 (25) –
CD4 count (cells/mm3) 16 141.25 35.5
No. of implants 33 – –
No. of implants that failed 3 (9.1) (% failed) –
Average time to failure (days) 29.7 –
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the distribution of implant site and implant size, re-
spectively. A total of three implants, in two patients,
failed prior to uncovering. This is shown graphically in
Fig. 1. In the patient with one failure, the implant failed at
post-op day 12 secondary to infection. In the patient with
two failures, two failed secondary to non-bony union, at
post-op days 31 and 46. Two of the three failures were
maxillary implants in the anterior arch, and the third was
in the mandibular posterior arch. A Kaplan-Meier survival
function is shown in Fig. 2.
Discussion
Since the AIDS epidemic reared its head in the 1980s,
the nature of this disease has quickly evolved from a
devastatingly debilitating disease to one of chronicity.
These patients are requesting for and are entitled to the
optimal restorative treatment plans, many of which
include dental endosteal implants. Several authors have
delved into the realm of implantology in the HIV-
positive patient, but there is only one study specifically
for the AIDS patient (CD4 count <200 cells/μL), though
patients were followed up for 6 months only [6]. The two
criteria generally used to ascertain the immunological
status and disease progression of the HIV-positive patient
are (1) viral load and (2) CD4 count. Viral load although
controversial in its ability to quantify disease progression is
stratified as high (5000–10,000 copies/mL), low (200–500
copies/mL), and as a treatment goal to be less than 50
copies/mL. The CD4 count has become the mainstay to
our infectious disease colleagues to tailor the medicinal
regiment of the HIV-positive and AIDS patient. The
prophylactic medications administered are based upon the
particular range of the CD4 count. This value is used as a
window to predict the type of organisms the patient is sus-
ceptible to. We stratified our study population by these
means in an effort to note any such trends.
As the HIV-positive patient reaches the low end of CD4
spectrum and manifests AIDS, this puts the patient in a
further immunocompromised state, opening the doors to
a multitude of opportunistic infections and neoplasia. One
may erroneously hesitate to offer this patient the full scope
of dental restorative options because of lack of awareness.
Intuitively, one may expect this person to be more prone
to infection, possessing a poorer quality of bone and
Table 2 Frequency table of implant site

















Table 3 Frequency table of implant size
Implant size Frequency Percent
4.5 × 11 7 21.21
4.5 × 8 1 3.03
4 × 11 10 30.3
4 × 8 13 39.39
5 × 11 1 3.03
5 × 8 1 3.03
Total 33 100
Fig. 1 Kaplan-Meier survival curve for individual implants, n = 33
Fig. 2 Number of implants and failures by quartiles of CD4
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compromised healing from surgery. These concerns may
lead the dental surgeon to favor non-surgical restorations,
prophylactic antibiotics, and a lower expectation of suc-
cess if implants are to be placed.
Generally speaking, the use of antibiotics in dental
implantology has been controversial. Amongst the rea-
sons for early (preloading) implant failure are bacterial
contamination, systemic disease, chemotherapy, over-
heating of bone, poor recipient site bone quality, and
poor bone to implant contact upon surgery. After the
prosthetic phase of the implant restoration, loading
forces exceeding the bone to implant interface is an
additional cause of early failure. Prophylactic antibiotics
are shown to reduce dental implant failure but do not
have much influence on post-operative infections [7].
The organisms most responsible for infections associated
with the failing implant in a “healthy” patient are pre-
dominantly Gram-negative anaerobic rods [8].
Anecdotally, many practitioners have decided to admin-
ister prophylactic antibiotics to all of their patients
receiving endosteal implants while others have taken a
more conservative approach. A survey of 102 periodon-
tists revealed that >50 % prescribe antibiotics in 10 spe-
cific periodontal or implant-related clinical circumstances
[9]. A metaanalysis of patients HIV positive and with
AIDS revealed no evidence of increased risk of complica-
tions associated with dental procedures [4].
HIV causes systemic infection with diverse multi-
organ system manifestation, musculoskeletal symptoms
often being the first clinical indication of the presence of
disease. Habermann et al. in a study of 41 patients noted
an increased infection rate of 12.7 % in HIV-positive he-
mophiliacs and non-hemophiliacs undergoing total joint
arthroplasty. They also reported that there was no differ-
ence in functional outcomes in non-hemophilic HIV-
positive and HIV-negative population after the surgery
[10]. Supporting the above findings, a retrospective ana-
lysis of patients from 2003 to 2010 showed that none
with CD4 indicative of AIDS at the time of total joint re-
placement developed implant infection [11].
In HIV-infected patients, CD4 count and albumin
levels negatively correlate with incidence of post-
operative sepsis, whereas surgical infections and previ-
ous major surgical procedures positively correlated with
the incidence of post-operative sepsis [12]. Thirty-five
HIV-infected patients undergoing abdominal operations
with pre-operative CD4 <200 or CD4/CD8 ratio <0.15
had overall higher post-operative sepsis morbidity [13].
Regarding dental procedures, a retrospective cross-
sectional study of 101 HIV patients was done from 2003
to 2005. Complication rate was found to be 2.2 % overall
and 4.8 % after invasive dental procedures. No relationship
was found between complications and immunological
values [14]. Another study examining healing response
after surgical crown lengthening in 21 patients with HIV
was analyzed, and none had post-operative complications
like delayed healing, infection, or prolonged bleeding [15].
In summary, our study indicated that dental endosteal
implants placed in a population of AIDS patients under
good surgical and prosthetic planning and surgical
technique have no significant difference in failure rate
than those placed in healthy patients. Therefore, this res-
toration should be made available to HIV-seropositive
patients, including those patients meeting the criteria for
an AIDS diagnosis. The success of the implants appears
to be independent of CD4 count.
Conclusions
Our study found a slightly higher failure rate of 10 % in
patients with AIDS, compared to widely accepted failure
rates in healthy patients at 5–7 %. A cohort sample size
of 33 may be considered small for statistical power; how-
ever, the results from this study could lead to larger fu-
ture prospective cohort studies with additional funding
to recruit a larger cohort and comparison groups. The
advent of new medical therapies has changed the face of
HIV/AIDS in the western world. These patients live long
and productive lives and should be offered the option of
root-formed implants as a viable alternative to fixed and
removable prosthetics.
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